WASHINGTON: The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced Wednesday. It’s the first step in an anticipated global rollout that could protect ...

The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced Wednesday. It's the first step in an anticipated global rollout that could protect millions – ...

Euro-GASP 2022 reveals rising gonorrhoea resistance to azithromycin in Europe, especially among men who have sex with men.

The US Food and Drug Administration on Wednesday approved Gilead Sciences' twice-yearly injection to prevent HIV -- a move the company hailed as a major breakthrough in the fight against ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

Glastonbury-goers have been advised to check they are vaccinated for measles amid a surge in cases of the highly infectious disease.

Read about why all four UK countries are rolling out a targeted vaccination programme against gonorrhoea in summer 2025.

Planned Parenthood clinics rely heavily on Medicaid funding, not to provide abortions, which is not permitted by federal law (except in cases of rape, incest or life-threatening health emergencies), ...

Let’s unite in demanding that every young person receives the education they deserve. Despite attempts to politicize the ...

Here @ Home welcomes Kristin Conrad and Laura Gayton with LewisGale to discuss these well-woman exams and what women can ...

Pharmaceutical company Gilead Sciences announced Wednesday the Food and Drug Administration (FDA) has approved its six-month, twice-yearly HIV PrEP injection, which was found in trials to be more ...